XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   126,913,992      
Beginning balance at Dec. 31, 2022 $ 998,023 $ 127 $ 1,160,882 $ (3,899) $ (159,087)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for ESPP (in shares)   96,733      
Issuance of common stock for ESPP 811   811    
Issuance of restricted stock, net of forfeitures (in shares)   114,738      
Issuance of restricted stock, net of forfeitures (147)   (147)    
Issuance of common stock for stock options (in shares)   75,028      
Issuance of common stock for stock options 751   751    
Stock issuance fees and expenses (4)   (4)    
Stock-based compensation expense 4,758   4,758    
Net unrealized gain on marketable securities, net of tax 1,065     1,065  
Net loss (30,795)       (30,795)
Ending balance (in shares) at Mar. 31, 2023   127,200,491      
Ending balance at Mar. 31, 2023 974,462 $ 127 1,167,051 (2,834) (189,882)
Beginning balance (in shares) at Dec. 31, 2022   126,913,992      
Beginning balance at Dec. 31, 2022 998,023 $ 127 1,160,882 (3,899) (159,087)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net unrealized gain on marketable securities, net of tax 2,053        
Net loss (73,642)        
Ending balance (in shares) at Sep. 30, 2023   127,261,476      
Ending balance at Sep. 30, 2023 947,428 $ 127 1,181,876 (1,846) (232,729)
Beginning balance (in shares) at Mar. 31, 2023   127,200,491      
Beginning balance at Mar. 31, 2023 974,462 $ 127 1,167,051 (2,834) (189,882)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for ESPP (in shares)   78,302      
Issuance of common stock for ESPP 1,029   1,029    
Issuance of restricted stock, net of forfeitures (in shares)   (194,448)      
Issuance of restricted stock, net of forfeitures (1,527)   (1,527)    
Issuance of common stock for stock options (in shares)   60,073      
Issuance of common stock for stock options 610   610    
Stock issuance fees and expenses (18)   (18)    
Stock-based compensation expense 5,705   5,705    
Net unrealized gain on marketable securities, net of tax 262     262  
Net loss (24,331)       (24,331)
Ending balance (in shares) at Jun. 30, 2023   127,144,418      
Ending balance at Jun. 30, 2023 956,192 $ 127 1,172,850 (2,572) (214,213)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for ESPP (in shares)   64,785      
Issuance of common stock for ESPP 863   863    
Issuance of restricted stock, net of forfeitures (in shares)   (35,670)      
Issuance of restricted stock, net of forfeitures (41)   (41)    
Issuance of common stock for stock options (in shares)   87,943      
Issuance of common stock for stock options 1,026   1,026    
Stock issuance fees and expenses (1)   (1)    
Stock-based compensation expense 7,179   7,179    
Net unrealized gain on marketable securities, net of tax 726     726  
Net loss (18,516)       (18,516)
Ending balance (in shares) at Sep. 30, 2023   127,261,476      
Ending balance at Sep. 30, 2023 $ 947,428 $ 127 1,181,876 (1,846) (232,729)
Beginning balance (in shares) at Dec. 31, 2023 127,369,142 127,369,142      
Beginning balance at Dec. 31, 2023 $ 941,537 $ 127 1,190,139 (1,674) (247,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for ESPP (in shares)   70,278      
Issuance of common stock for ESPP 917   917    
Issuance of restricted stock, net of forfeitures (in shares)   (17,398)      
Issuance of restricted stock, net of forfeitures (199)   (199)    
Issuance of common stock for stock options (in shares)   12,764      
Issuance of common stock for stock options 102   102    
Stock issuance fees and expenses (4)   (4)    
Stock-based compensation expense 7,774   7,774    
Net unrealized gain on marketable securities, net of tax 344     344  
Net loss (27,061)       (27,061)
Ending balance (in shares) at Mar. 31, 2024   127,434,786      
Ending balance at Mar. 31, 2024 $ 923,410 $ 127 1,198,729 (1,330) (274,116)
Beginning balance (in shares) at Dec. 31, 2023 127,369,142 127,369,142      
Beginning balance at Dec. 31, 2023 $ 941,537 $ 127 1,190,139 (1,674) (247,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for stock options (in shares) 373,522        
Net unrealized gain on marketable securities, net of tax $ 1,031        
Net loss $ (63,402)        
Ending balance (in shares) at Sep. 30, 2024 128,061,944 128,061,944      
Ending balance at Sep. 30, 2024 $ 908,210 $ 128 1,219,182 (643) (310,457)
Beginning balance (in shares) at Mar. 31, 2024   127,434,786      
Beginning balance at Mar. 31, 2024 923,410 $ 127 1,198,729 (1,330) (274,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for ESPP (in shares)   102,112      
Issuance of common stock for ESPP 1,280   1,280    
Issuance of restricted stock, net of forfeitures (in shares)   32,607      
Issuance of restricted stock, net of forfeitures (1,631)   (1,631)    
Issuance of common stock for stock options (in shares)   281,608      
Issuance of common stock for stock options 2,321 $ 1 2,320    
Stock issuance fees and expenses (3)   (3)    
Stock-based compensation expense 8,841   8,841    
Net unrealized gain on marketable securities, net of tax 308     308  
Net loss (18,642)       (18,642)
Ending balance (in shares) at Jun. 30, 2024   127,851,113      
Ending balance at Jun. 30, 2024 915,884 $ 128 1,209,536 (1,022) (292,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for ESPP (in shares)   75,238      
Issuance of common stock for ESPP 897   897    
Issuance of restricted stock, net of forfeitures (in shares)   56,443      
Issuance of restricted stock, net of forfeitures (603)   (603)    
Issuance of common stock for stock options (in shares)   79,150      
Issuance of common stock for stock options 886   886    
Stock issuance fees and expenses (4)   (4)    
Stock-based compensation expense 8,470   8,470    
Net unrealized gain on marketable securities, net of tax 379     379  
Net loss $ (17,699)       (17,699)
Ending balance (in shares) at Sep. 30, 2024 128,061,944 128,061,944      
Ending balance at Sep. 30, 2024 $ 908,210 $ 128 $ 1,219,182 $ (643) $ (310,457)